SCHEMBL30173270

SCHEMBL30173270

Clc1c(-c2ccc3cc[nH]c3c2)cnc2[nH]ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNK O75909 1/20 0.49
CDK12 Q9NYV4 1/20 0.49
PRKCI P41743 4/20 0.48
AXL P30530 2/20 0.48
MAP3K11 Q16584 5/20 0.47
NUDT1 P36639 2/20 0.45
DYRK1A Q13627 2/20 0.43
PLK4 O00444 1/20 0.43
CHEK1 O14757 1/20 0.43
PDPK1 O15530 1/20 0.43
DYRK3 O43781 1/20 0.43
JAK2 O60674 1/20 0.43
ROCK2 O75116 1/20 0.43
PRKD3 O94806 1/20 0.43
MAP4K4 O95819 1/20 0.43
ABL1 P00519 1/20 0.43
NTRK1 P04629 1/20 0.43
INSR P06213 1/20 0.43
FYN P06241 1/20 0.43
CDK1 P06493 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28602138 1.00 CCNK (0.49) CCNKCDK12PRKCIAXLMAP3K11
SCHEMBL28603791 0.83 PRKCI (0.51) CCNKCDK12PRKCIAXLMAP3K11
SCHEMBL30173290 0.83 PRKCI (0.51) CCNKCDK12PRKCIAXLMAP3K11
SCHEMBL30173298 0.79 RPS6KA3 (0.49) CCNKCDK12PRKCIAXLNUDT1
SCHEMBL28596894 0.79 RPS6KA3 (0.49) CCNKCDK12PRKCIAXLNUDT1
SCHEMBL28596854 0.78 PRKCI (0.59) CCNKCDK12PRKCIAXLNUDT1
SCHEMBL30173348 0.78 PRKCI (0.59) CCNKCDK12PRKCIAXLNUDT1
SCHEMBL28606321 0.77 NUDT1 (0.68) PRKCIAXLNUDT1DYRK1AJAK2
SCHEMBL28609163 0.77 AXL (0.61) CCNKCDK12PRKCIAXLNUDT1
SCHEMBL30173316 0.77 AXL (0.61) CCNKCDK12PRKCIAXLNUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113200983-B Compound with pyrrolopyridine structure, preparation method and medical application 中国药科大学 2023-01-03 CN disclosed